The House Energy and Commerce Committee will unveil a second draft of its highly watched 21st Century Cures legislation next week, and lawmakers have asked top FDA and NIH officials to testify on the measure next Thursday (April 30). The committee offered no details on how the second draft will differ from the first iteration of the bill, unveiled in January, but signaled changes are still under discussion. “Staff continues to work together around the clock as they have for...